We are live on
!
Find out more
FNA
First National Advisers Portfolio holdings
AUM
$712M
1-Year Est. Return
30.64%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+30.64%
3 Year Est. Return
+87.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$683M
AUM Growth
+$58.2M
(+9.3%)
Cap. Flow
+$12.2M
Cap. Flow
% of AUM
1.79%
Top 10 Holdings %
Top 10 Hldgs %
36.12%
Holding
226
New
14
Increased
153
Reduced
40
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$3.97M |
| 2 |
Arista Networks
ANET
|
+$2.33M |
| 3 |
BCPC
Balchem Corp
BCPC
|
+$2.09M |
| 4 |
Quest Diagnostics
DGX
|
+$1.56M |
| 5 |
DFAI
Dimensional International Core Equity Market ETF
DFAI
|
+$1.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$2.54M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$1.95M |
| 3 |
Comcast
CMCSA
|
+$1.76M |
| 4 |
CDW
CDW
|
+$1.48M |
| 5 |
Medtronic
MDT
|
+$1.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.89% |
| 2 | Financials | 15.07% |
| 3 | Consumer Discretionary | 8.56% |
| 4 | Healthcare | 8.13% |
| 5 | Industrials | 8.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Blackbaud
BLKB
$1.94B
| $413K | 0.06% |
6,436
+380
| +6% | +$23.8K |
|
177
Lincoln Electric
LECO
$14.2B
| $411K | 0.06% |
1,981
+116
| +6% | +$22.2K |
|
178
Wyndham Hotels & Resorts
WH
$5.56B
| $406K | 0.06% |
4,994
+294
| +6% | +$24.6K |
|
179
Diodes
DIOD
$3.78B
| $389K | 0.06% |
7,348
+1,879
| +34% | +$82.6K |
|
180
Molina Healthcare
MOH
$10.2B
| $386K | 0.06% |
1,297
+78
| +6% | +$24.5K |
|
181
Ambarella
AMBA
$3.77B
| $386K | 0.06% |
5,840
+345
| +6% | +$18.3K |
|
182
UMB Financial
UMBF
$11.1B
| $375K | 0.06% |
3,570
-105
| -3% | -$10.5K |
|
183
Onto Innovation
ONTO
$12.9B
| $370K | 0.05% |
3,663
+891
| +32% | +$95.2K |
|
184
Automatic Data Processing
ADP
$106B
| $366K | 0.05% |
1,186
+3
| +0.3% | +$921 |
|
185
Nexstar Media Group
NXST
$5.82B
| $362K | 0.05% |
2,093
+124
| +6% | +$20.3K |
|
186
Northern Trust
NTRS
$33.3B
| $360K | 0.05% |
2,843
| – | – |
|
187
iShares Russell Mid-Cap ETF
IWR
$56B
| $359K | 0.05% |
3,900
| – | – |
|
188
EnerSys
ENS
$6.78B
| $354K | 0.05% |
4,131
-418
| -9% | -$36.4K |
|
|
BLD
189
DELISTED
TopBuild
BLD
| $352K | 0.05% |
1,087
+65
| +6% | +$19.3K |
|
190
Alliant Energy
LNT
$18.3B
| $350K | 0.05% |
5,786
-300
| -5% | -$18.4K |
|
191
Domino's
DPZ
$11.5B
| $345K | 0.05% |
766
+47
| +7% | +$22.1K |
|
192
Northern Oil and Gas
NOG
$2.3B
| $343K | 0.05% |
12,085
+711
| +6% | +$19.1K |
|
193
Vanguard Morningstar Mega Cap Growth ETF
MGK
$32.5B
| $333K | 0.05% |
+4,550
| New | +$300K |
|
194
Leidos
LDOS
$14.5B
| $322K | 0.05% |
2,041
| – | – |
|
195
Fortune Brands Innovations
FBIN
$5.88B
| $316K | 0.05% |
6,132
+362
| +6% | +$18.9K |
|
196
SM Energy
SM
$7.8B
| $297K | 0.04% |
12,026
+708
| +6% | +$17.1K |
|
197
Palantir
PLTR
$295B
| $293K | 0.04% |
+2,149
| New | +$252K |
|
198
Dimensional US Core Equity 2 ETF
DFAC
$47.9B
| $292K | 0.04% |
8,158
| – | – |
|
199
Vanguard Information Technology ETF
VGT
$139B
| $289K | 0.04% |
3,480
+128
| +4% | +$9.31K |
|
200
AMN Healthcare
AMN
$1.3B
| $288K | 0.04% |
13,934
-134
| -1% | -$2.79K |
|
Similar funds
PCS
AMPWP
DCM
TLP
SSP
DCM
IWP
DIA
First National Advisers's Q2 2025 Portfolio in Review
As of Q2 2025, First National Advisers held 226 positions worth $683M, up 9.3% from $625M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
First National Advisers's Q2 2025 filing shows 14 new, 153 increased, 40 reduced and 5 closed positions. Its largest new stake was Arista Networks: 26,985 shares worth $2.76M. The largest sale was Jazz Pharmaceuticals, an estimated $2.54M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.
- First National Advisers's largest Q2 2025 buy was Arista Networks: 26,985 shares worth $2.76M.
- First National Advisers added most to AbbVie in Q2 2025, an estimated $3.97M increase.
- First National Advisers's biggest Q2 2025 reduction was Thermo Fisher Scientific, cutting an estimated $1.95M.
- First National Advisers fully exited Jazz Pharmaceuticals in Q2 2025, selling an estimated $2.54M.
- First National Advisers's ten largest holdings make up 36% of its $683M portfolio in Q2 2025.
- First National Advisers opened 14 new positions and closed 5 in Q2 2025.
- First National Advisers's portfolio value rose 9.3% quarter-over-quarter to $683M.
Based on First National Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.